Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations

被引:35
作者
Ahlgren, C. [1 ]
Oden, A. [2 ]
Toren, K. [3 ]
Andersen, O.
机构
[1] Sahlgrens Univ Hosp, Dept Neurol, Inst Neurosci & Physiol, S-41345 Gothenburg, Sweden
[2] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Inst Occupat & Environm Med, S-41345 Gothenburg, Sweden
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 119卷 / 05期
关键词
multiple sclerosis; neuroepidemiology; infections; DIAGNOSTIC-CRITERIA; PREDICT CONVERSION; DISEASES; PROGRAM; RISK; AGE; GUIDELINES; EXPERIENCE; COUNTRIES; CHILDREN;
D O I
10.1111/j.1600-0404.2008.01131.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Viral childhood infections may be involved in the multiple sclerosis (MS) pathogenesis. Following national Swedish vaccination programs, measles sharply declined in the 1970s, and measles, mumps, and rubella were virtually eliminated in cohorts born from 1981. To examine whether the vaccination induced reduction in these infections influences the MS incidence. In addition, the public health aspect justified an early evaluation of beneficial as well as harmful effects of mass vaccinations. From an incidence material of 534 MS patients, born 1959-1990, we selected one unvaccinated cohort and four cohorts, each corresponding to a vaccination program (MS patients = 251). With the ability to detect a decrease by 30-35%, and an increase by 37-48% in the MS incidence in the first three cohorts, we found no vaccination related MS incidence changes. The background MS incidence showed a significant gradual age dependent increase. While the present follow-up provided limited power in the last cohort, there is no evidence as yet that the radical decline in three viral infections influenced the MS incidence. However, the increasing background MS incidence of unknown cause may have concealed a reduction in MS risk associated with mass vaccinations.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 38 条
  • [1] Elimination of childhood diseases: Possible influence on the incidence of multiple sclerosis soon detectable
    Ahlgren, C
    Taranger, J
    Johansson, L
    Andersen, O
    [J]. NEUROEPIDEMIOLOGY, 2002, 21 (06) : 306 - 309
  • [2] MEASLES VACCINATION DOES NOT PREVENT MULTIPLE-SCLEROSIS
    BANSIL, S
    TROIANO, R
    DOWLING, PC
    COOK, SD
    [J]. NEUROEPIDEMIOLOGY, 1990, 9 (05) : 248 - 254
  • [3] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
    Barkhof, F
    Filippi, M
    Miller, DH
    Scheltens, P
    Campi, A
    Polman, CH
    Comi, G
    Ader, HJ
    Losseff, N
    Valk, J
    [J]. BRAIN, 1997, 120 : 2059 - 2069
  • [4] Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002:: results from INTERGENE and GOT-MONICA
    Berg, CM
    Lissner, L
    Aires, N
    Lappas, G
    Torén, K
    Wilhelmsen, L
    Rosengren, A
    Thelle, DS
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (02): : 115 - 125
  • [5] BJORVATN B, 1976, LAKARTIDNINGEN, V75, P2295
  • [6] Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination
    Bottiger, M
    Forsgren, M
    [J]. VACCINE, 1997, 15 (14) : 1538 - 1544
  • [7] SWEDISH EXPERIENCE OF 2 DOSE VACCINATION PROGRAM AIMING AT ELIMINATING MEASLES, MUMPS, AND RUBELLA
    BOTTIGER, M
    CHRISTENSON, B
    ROMANUS, V
    TARANGER, J
    STRANDELL, A
    [J]. BRITISH MEDICAL JOURNAL, 1987, 295 (6608) : 1264 - 1267
  • [8] Bottiger M, 1974, Lakartidningen, V71, P1949
  • [9] Breslow NE, 1987, DESIGN ANAL COHORT S, V2
  • [10] A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
    Brex, PA
    Ciccarelli, O
    O'Riordan, JI
    Sailer, M
    Thompson, AJ
    Miller, DH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) : 158 - 164